414
Views
0
CrossRef citations to date
0
Altmetric
Research Article

YY1/circCTNNB1/miR-186-5p/YY1 positive loop aggravates lung cancer progression through the Wnt pathway

, , , , &
Article: 2369006 | Received 27 Nov 2023, Accepted 12 Jun 2024, Published online: 24 Jun 2024

Figures & data

Figure 1. The higher expression of circCTNNB1 was discovered in lung cancer.

(a) The mRNA expression of circCTNNB1 was examined in lung cancer tissues (n = 40) and normal tissues (n = 40) through RT-qPCR. (b) The prognosis of lung cancer patients with higher (n = 20) or lower (n = 20) circCTNNB1 expression was verified. (c) The mRNA expression of circCTNNB1 was determined in human bronchial epithelial cell line (BEAS-2B) and lung cancer cell lines (H1299, A549, PC9, and H1975) through RT-qPCR. (d) The relative abundance of circCTNNB1 and CTNNB1 was evaluated after RNase R treatment through RT-qPCR. (e) The relative abundance of circCTNNB1 and CTNNB1 was assessed after Actinomycin D treatment through RT-qPCR. (F) The location of circCTNNB1 in cytoplasm or nuclear was verified through RT-qPCR. ***p < 0.001.
Figure 1. The higher expression of circCTNNB1 was discovered in lung cancer.

Figure 2. CircCTNNB1 facilitated lung cancer cell proliferation, migration, invasion, and suppressed cell senescence.

(a) The knockdown efficiency of circCTNNB1 was confirmed through RT-qPCR in the sh-NC, sh-circCTNNB1#1, sh-circCTNNB1#2, and sh-circCTNNB1#3 groups. (b) The cell proliferation was tested through CCK-8 assay in the sh-NC and sh-circCTNNB1 groups. (c-d) The cell migration and invasion were examined through Transwell assay in the sh-NC and sh-circCTNNB1 groups. (e) The cell senescence was evaluated through SA-β-gal assay in the sh-NC and sh-circCTNNB1 groups. ***p < 0.001.
Figure 2. CircCTNNB1 facilitated lung cancer cell proliferation, migration, invasion, and suppressed cell senescence.

Figure 3. Knockdown of circCTNNB1 retarded the Wnt pathway.

(a) The nuclear translocation of β-catenin was notarized through IF assay in the sh-NC and sh-circCTNNB1 groups. (b) The protein expressions of WNT3A, β-catenin, and c-myc were determined through western blot in the sh-NC and sh-circCTNNB1 groups. ***p < 0.001.
Figure 3. Knockdown of circCTNNB1 retarded the Wnt pathway.

Figure 4. CircCTNNB1 combined with miR-186-5p to target YY1.

(a) The binding sites between circCTNNB1 and miR-186-5p (YY1) were displayed. (b-c) The binding ability between circCTNNB1 and miR-186-5p (YY1) was confirmed through luciferase reporter and RIP assays. (d) The expressions of miR-186-5p and YY1 were detected through RT-qPCR. (e) The protein expression of YY1 was assessed after circCTNNB1 knockdown or miR-186-5p mimic through western blot. (f) The expressions of miR-186-5p and YY1 were confirmed in lung cancer tissues and normal tissues through RT-qPCR. (g) The expressions of miR-186-5p and YY1 were tested in lung cancer cell lines and normal bronchial epithelial cell line (BEAS-2B) through RT-qPCR. ***p < 0.001.
Figure 4. CircCTNNB1 combined with miR-186-5p to target YY1.

Figure 5. YY1 overexpression can rescue the decreased cell proliferation, migration, invasion, and the increased cell senescence mediated by circCTNNB1 suppression.

Groups were divided into the sh-NC, sh-circCTNNB1, and sh-circCTNNB1+pcDNA3.1/YY1 groups. (a) The cell proliferation was measured through a CCK-8 assay. (b-c) The cell migration and invasion were assessed through Transwell assay. (d) The cell senescence was confirmed through SA-β-gal assay. ***p < 0.001 vs the sh-NC group; ###p < 0.001 vs the sh-circCTNNB1.
Figure 5. YY1 overexpression can rescue the decreased cell proliferation, migration, invasion, and the increased cell senescence mediated by circCTNNB1 suppression.

Figure 6. YY1 overexpression can rescue the retarded Wnt pathway mediated by circCTNNB1 knockdown.

Groups were divided into the sh-NC, sh-circCTNNB1, and sh-circCTNNB1+pcDNA3.1/YY1 groups. (a) The nuclear translocation of β-catenin was examined through IF assay. (b) The protein expressions of WNT3A, β-catenin, and c-myc were determined through western blot. **p < 0.01, ***p < 0.001 vs the sh-NC group; ##p < 0.01, ###p < 0.001 vs the sh-circCTNNB1.
Figure 6. YY1 overexpression can rescue the retarded Wnt pathway mediated by circCTNNB1 knockdown.

Figure 7. YY1 can transcriptionally activate circCTNNB1 to form YY1/circCTNNB1/miR-186-5p/YY1 loop.

(a) The correlation between circCTNNB1 and YY1 was verified. (b) The expression of circCTNNB1 was tested after YY1 knockdown through RT-qPCR. (b) The binding site of YY1 was displayed. (d-e) The binding ability between YY1 and the promoter of circCTNNB1 was measured through RIP and luciferase reporter assays. ***p < 0.001.
Figure 7. YY1 can transcriptionally activate circCTNNB1 to form YY1/circCTNNB1/miR-186-5p/YY1 loop.

Figure 8. CircCTNNB1 accelerated tumour growth in vivo.

(a-c) The tumour size, volume, and weight were evaluated in the sh-NC and sh-circCTNNB1 groups. (d) The Ki67 expression was examined through IHC assay in the sh-NC and sh-circCTNNB1 groups. ***p < 0.001.
Figure 8. CircCTNNB1 accelerated tumour growth in vivo.
Supplemental material

Supplemental Material

Download TIFF Image (56 MB)

Cell STR file.zip

Download Zip (2.3 MB)

Data availability statement

The data that support the findings of this study are available from the corresponding author.